Preliminary Web-Based Measures Development for GHB: Expectancies, Functions, and Withdrawal

REFERENCES

• Laborit H. Sodium 4-hydroxybytyrate. Int J Neuropharmacol 1964; 3:433–452.
   PubMedGoogle Scholar
• Dyer JE. γ-Hydroxybutyrate: A health-food product producing coma and seizure-like activity. Am J Emerg Med 1991; 9(4):321–324.
   PubMed Web of Science ®Google Scholar
• CDC. Multistate outbreak of poisonings associated with illicit use of gamma hydroxyl butyrate. MMWR 1990; 39:861–863.
   PubMedGoogle Scholar
• CDC. Gamma hydroxy butyrate use – New York and Texas 1995–1996. MMWR 1997; 46:281–283.
   PubMedGoogle Scholar
• Zvosec DL, Smith SW, McCutcheon JR, Spillane J, Hall BJ, Peacock EA. Adverse events, including death, associated with the use of 1,4-butanediol. N Engl J Med 2001; 344(2):87–94.
   PubMed Web of Science ®Google Scholar
• CDC. Adverse events associated with ingestion of gamma-butyrolactone – Minnesota, New Mexico, and Texas, 1998-1999. MMWR 1999; 48(7):137–140.
   PubMedGoogle Scholar
• Anderson IB, Kim SY, Dyer JE, Burkhardt CB, Iknoian JC, Walsh MJ, Blanc PD. Trends in γ-Hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003. Ann Emerg Med 2006; 47(2):177–183.
   PubMed Web of Science ®Google Scholar
• McDaniel CH, Miotto KA. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: Five case studies. J Psychoactive Drugs 2001; 33:143.
   PubMed Web of Science ®Google Scholar
• Zvosec DL, Smith SW, Porrata T, Strobl AQ, Dyer JE. Case series of 226 γ-hydroxybutyrate-associated deaths: Lethal toxicity and trauma. Am J Emerg Med 2011; 29(3):319–332.
   PubMed Web of Science ®Google Scholar
• Miotto K, Darakjian J, Basch J, Murray S, Zogg J, Rawson R. Gamma-hydroxybutyric acid: Patterns of use, effects and withdrawal. Am J Addict 2001; 10(3):232–241.
   PubMed Web of Science ®Google Scholar
• Dyer JE, Roth B, Hyma BA. Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med 2001; 37(2):147–153.
   PubMed Web of Science ®Google Scholar
• Sumnall HR, Woolfall K, Edwards S, Cole JC, Beynon CM. Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). Drug Alcohol Depend 2008; 92(1–3):286–290.
   PubMed Web of Science ®Google Scholar
• Barker JC, Harris SL, Dyer JE. Experiences of gamma hydroxybutyrate (GHB) ingestion: A focus group study. J Psychoactive Drugs 2007; 39(2):115–129.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Levounis P. Gamma hydroxybutyrate: An ethnographic study of recreational use and abuse. J Psychoactive Drugs 2008; 40(3):245–253.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Darke S, Dillon P. GHB use among Australians: Characteristics use patterns and associated harm. Drug Alcohol Depend 2002; 67(1):89–94.
   PubMed Web of Science ®Google Scholar
• Barker JC, Karsoho H. Hazardous use of gamma hydroxybutyrate: Driving under the influence. Subst Use Misuse 2008; 43(11):1507–1520.
   PubMed Web of Science ®Google Scholar
• Németh Z, Kun B, Demetrovics Z. The involvement of gamma-hydroxybutyrate in reported sexual assaults: A systematic review. J Psychopharmacol 2010; 24(9):1281–1287.
   PubMed Web of Science ®Google Scholar
• Li J, Stokes SA, Woeckener A. A tale of novel intoxication: Seven cases of gamma-hydroxybutyric acid overdose. Ann Emerg Med 1998; 31(6):723–728.
   PubMed Web of Science ®Google Scholar
• FDA. FDA Warns about Products Containing Gamma-Butyrolactone or GBL and Asks Companies to Issue a Recall. Rockville, MD: US Department of Health and Human Services, Public Health Service, Food and Drug Administration, 1999 ( Talk paper T99–5).
   Google Scholar
• Liechti ME, Kunz I, Greminger P, Speich R, Kupferschmidt H. Clinical features of gamma-hydroxybutyrate and gamma-butyrolcatone toxicity and concomitant drug and alcohol use. Drug Alcohol Depend 2006; 81:323–326.
   PubMed Web of Science ®Google Scholar
• Thai D, Dyer JE, Benowitz NL, Haller CA. Gamma-hydroxybutyrate and ethanol effects and interactions in humans. J Clin Psychopharmacol 2006; 26(5):524–529.
   PubMed Web of Science ®Google Scholar
• Mason PE, Kerns WP. Gamma hydroxybutyric acid (GHB) intoxication. Acad Emerg Med 2002; 9(7):730–739.
   PubMed Web of Science ®Google Scholar
• Snead III, OC, Gibson KM. Gamma-hydroxybutyric acid. N Engl J Med 2005; 352(26):2721–2732.
   PubMed Web of Science ®Google Scholar
• Freese TE, Miotto K, Reback CJ. The effects and consequences of selected club drugs. J Subst Abuse Treat 2002; 23(2):151–156.
   PubMed Web of Science ®Google Scholar
• Barth KS, Hines S, Albanese RP. Permanent neurologic damage from chronic gamma hydroxybutyrate abuse. Am J Addict 2006; 15:483–484.
   PubMed Web of Science ®Google Scholar
• Reips U. Web-Based Methods. Handbook of Multi-Method Measurement in Psychology. Washington, DC: American Psychological Association, 2006; 73–85, xiv, 553 pp.
   Google Scholar
• Miller ET, Neal DJ, Roberts LJ, Baer JS, Cressler SO, Metrik J, Marlatt AG. Test-retest reliability of alcohol measures: Is there a difference between Internet-based assessment and traditional methods? Psychol Addict Behav 2002; 16(1):56–63.
   PubMed Web of Science ®Google Scholar
• Nicholson T, White J, Duncan DF. DRUGNET: A pilot study of adult recreational drug use via the WWW. J Subst Abuse 1998; 19:109–121.
   Google Scholar
• Nicholson T, White J, Duncan DF. A survey of adult recreational drug use via the World Wide Web: The DRUGNET study. J Psychoactive Drugs 1999; 31:415–422.
   PubMed Web of Science ®Google Scholar
• Pasveer KA, Ellard JH. The making of a personality inventory: Help from the WWW. Behav Res Meth Instrum Comput 1998; 30:309–313.
   Google Scholar
• Velicer W, Eaton C, Fava J. Construct explication through factor or component analysis. In Problems and Solutions in Human Assessment. Goffin R, Helms E, eds. Boston, MA: Kluwer, 2000; 41–71.
   Google Scholar
• Zwick WR, Velicer WF. Comparison of five rules for determining the number of components to retain. Psychol Bull 1986; 99(3):432–442.
   Web of Science ®Google Scholar
• Miller WR, ed.. Enhancing Motivation for Change in Substance Abuse Treatment (DHHS TIP#35). Rockville, MD: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, 1999.
   Google Scholar
• Brown SA, Christiansen BA, Goldman MS. The alcohol expectancy questionnaire: An instrument for the assessment of adolescent and adult alcohol expectancies. J Stud Alcohol 1987; 48:483–491.
   PubMed Web of Science ®Google Scholar
• Schafer J, Brown SA. Marijuana and cocaine effect expectancies and drug use patterns. J Consult Clin Psychol 1991; 59:558–565.
   PubMed Web of Science ®Google Scholar
• Stacy AW, Dent CW, Sussman S, Raynor A. Expectancy accessibility and the influence of outcome expectancies on adolescent smokeless tobacco use. J Appl Soc Psychol 1990; 20(10):802–817.
   Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4 ed.). Washington, DC: American Psychiatric Association, 1994.
   Google Scholar
• Stuppaeck CH, Barnas C, Falk M, Guenther V, Hummer M, Oberbauer H, Pycha R, Whitworth AB, Fleischhacker WW. Assessment of the alcohol withdrawal syndrome: Validity and reliability for the translated and modified Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-A). Addiction 1994; 89:1287–1292.
   PubMed Web of Science ®Google Scholar
• First et al. cite. Use instead: First MB, Spitzer RL, Gibbon M, & Williams, JBW: Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, D.C.: American Psychiatric Press, Inc., 1996.
   Google Scholar
• Guadagnoli E, Velicer WF. Relation of sample size to the stability of component patterns. Psychol Bull 1988; 103(2):265–275.
   PubMed Web of Science ®Google Scholar
• Redding C, Maddock J, Rossi J. The sequential approach to measurement of health behavior constructs: Issues in selecting and developing measures. Calif J Health Promot 2006; 4:83–101.
   Google Scholar
• Babor TF, Webb C, Burleson JA, Kaminer Y. Subtypes of classifying adolescents with marijuana use disorders: Construct validity and clinical implications. Addiction 2002; 97:58–69.
   PubMed Web of Science ®Google Scholar
• Dennis M, Titus JC, Diamond G, Donaldson J, Godley SH, Tims FM, Webb C, Kaminer Y, Babor MC, Roebuck MD, Godley G, Hamilton N, Liddle H, Scott CK. The cannabis youth treatment (CYT) experiment: Rationale, study design and analysis plans. Addiction 2002; 97(Suppl. 1):16–34.
   PubMed Web of Science ®Google Scholar